Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 06-2003 | 12-2002 | 06-2002 | 12-2001 | |
| Sales | 0 | 10 | 200 | 200 | 0 |
| Gross Profit | 0 | 10 | 200 | 200 | 0 |
| Operating Expenses | 890 | 2,130 | 2,310 | 2,310 | 1,810 |
| Operating Income | -890 | -2,120 | -2,110 | -2,110 | -1,810 |
| Other Income | 100 | 60 | 20 | 20 | -60 |
| Pre-tax Income | -790 | -2,060 | -2,090 | -2,090 | -1,870 |
| Income Tax | 0 | 0 | -150 | -150 | 0 |
| Net Income Continuous | -2,066 | -2,066 | -1,939 | -1,939 | -1,877 |
| Net Income | $-790 | $-2,060 | $-1,930 | $-1,930 | $-1,870 |
| EPS Basic Total Ops | -13,600.00 | -340.00 | -16,000.00 | -400.00 | -19,200.00 |
| EPS Basic Continuous Ops | -20,660.00 | -350.17 | -19,390.00 | -403.96 | -18,770.00 |
| EPS Diluted Total Ops | -13,600.00 | -340.00 | -16,000.00 | -400.00 | -19,200.00 |
| EPS Diluted Continuous Ops | -20,660.00 | -350.17 | -19,390.00 | -403.96 | -18,770.00 |
| EBITDA(a) | $-880 | $-2,090 | $-2,090 | $-2,090 | $-1,790 |